Reuters logo
BRIEF-Tigenix says EPO issues key patent for adipose-derived stem cell composition
January 22, 2015 / 6:12 AM / 3 years ago

BRIEF-Tigenix says EPO issues key patent for adipose-derived stem cell composition

Jan 22 (Reuters) - Tigenix Nv

* Announced today that European Patent Office (EPO) has issued European Patent EP2292736 relating to an adipose-derived stem cell composition

* Claims of granted patent cover both a specified population of expanded adipose-derived multipotent cells and their therapeutic uses, as well as pharmaceutical compositions of such cells

* Issuance of this patent reinforces Tigenix’s intellectual property portfolio of 24 patent families which now includes 14 granted patents Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below